STOCK TITAN

Empyrean/Amos Meron disclose 1.98M MTAL shares (8.61%) — MTAL

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Metals Acquisition Corp. II reports that Empyrean Capital Partners, LP and Amos Meron together beneficially own 1,980,000 Class A ordinary shares representing 8.61% of the class. The filing states this percentage is calculated using 23,000,000 Class A Ordinary Shares outstanding as reported in the issuer's prospectus on March 12, 2026 and in the issuer's Form 8-K on March 19, 2026.

The Schedule 13G discloses that the reported position is held with shared voting and dispositive power of 1,980,000 shares. The statement is a joint filing by Empyrean Capital Partners, LP (as investment manager) and Mr. Amos Meron (as managing member), signed on May 15, 2026.

Positive

  • None.

Negative

  • None.

Insights

Passive Schedule 13G reports a >5% ownership stake under shared control.

The filing shows Empyrean Capital Partners, LP and Amos Meron together beneficially own 1,980,000 shares (8.61%) with shared voting and dispositive power. The percentage basis is tied to an aggregate of 23,000,000 Class A Ordinary Shares reported in the issuer's prospectus and Form 8-K in March 2026.

Because this is a Schedule 13G-style passive disclosure, the filing signals ownership above the 5% threshold but does not indicate active control or a change in company governance; subsequent filings would show any directional changes.

Beneficially owned shares 1,980,000 shares Amount beneficially owned by Empyrean/Amos Meron
Percent of class 8.61% Percent of Class A ordinary shares outstanding
Shares outstanding (basis) 23,000,000 shares Aggregate outstanding reported in prospectus on <date>March 12, 2026</date>
Filing signature date May 15, 2026 Date signatures were provided on the Schedule 13G
Schedule 13G regulatory
"This Schedule 13G discloses beneficial ownership of Class A Ordinary Shares"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
shared dispositive power financial
"Shared Dispositive Power 1,980,000.00 as reported in Item 4"
over-allotment option market
"full exercise of the underwriters' over-allotment option as described therein"
An over-allotment option is a special agreement that allows underwriters to sell more shares than initially planned if demand is high. Think of it like a retailer offering extra units of a popular product to meet additional customer interest. This option helps ensure the full sale is completed and can also give investors extra shares if they want more.





G60420125

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Empyrean Capital Partners, LP
Signature:/s/ Jennifer Norman
Name/Title:Chief Compliance Officer
Date:05/15/2026
Amos Meron
Signature:/s/ Amos Meron
Name/Title:Amos Meron, Individually
Date:05/15/2026
Exhibit Information

Exhibit 99.1 Joint Filing Agreement

FAQ

What stake does Empyrean Capital report in MTAL?

Empyrean Capital Partners and Amos Meron report beneficial ownership of 1,980,000 shares, equal to 8.61% of MTAL's Class A ordinary shares based on a 23,000,000 share base reported in March 2026.

Does this filing show who controls the shares for MTAL?

The Schedule 13G states the shares are held with shared voting and dispositive power of 1,980,000 shares. It attributes investment-manager and managing-member roles rather than sole individual control.

What dates anchor the ownership calculation for MTAL?

The ownership percentage is calculated using the issuer's reported outstanding shares in the prospectus on March 12, 2026 and the Form 8-K on March 19, 2026, as cited in the filing.

When was the Schedule 13G signed for MTAL?

The joint Schedule 13G was signed by the reporting persons on May 15, 2026, with Jennifer Norman signing as Chief Compliance Officer and Amos Meron signing individually.